Literature DB >> 29351447

Cigarette smoke dampens antiviral signaling in small airway epithelial cells by disrupting TLR3 cleavage.

Parker F Duffney1, Claire E McCarthy1, Aitor Nogales2, Thomas H Thatcher3,4, Luis Martinez-Sobrido2, Richard P Phipps1,2,3,4, Patricia J Sime1,2,3,4.   

Abstract

Cigarette smokers and people exposed to second-hand smoke are at an increased risk for pulmonary viral infections, and yet the mechanism responsible for this heightened susceptibility is not understood. To understand the effect of cigarette smoke on susceptibility to viral infection, we used an air-liquid interface culture system and exposed primary human small airway epithelial cells (SAEC) to whole cigarette smoke, followed by treatment with the viral mimetic polyinosinic polycytidylic acid (poly I:C) or influenza A virus (IAV). We found that prior smoke exposure strongly inhibited production of proinflammatory (interleukin-6 and interleukin-8) and antiviral [interferon-γ-induced protein 10 (IP-10) and interferons] mediators in SAECs in response to poly I:C and IAV infection. Impaired antiviral responses corresponded to increased infection with IAV. This was associated with a decrease in phosphorylation of the key antiviral transcription factor interferon response factor 3 (IRF3). Here, we found that cigarette smoke exposure inhibited activation of Toll-like receptor 3 (TLR3) by impairing TLR3 cleavage, which was required for downstream phosphorylation of IRF3 and production of IP-10. These results identify a novel mechanism by which cigarette smoke exposure impairs antiviral responses in lung epithelial cells, which may contribute to increased susceptibility to respiratory infections.

Entities:  

Keywords:  Toll-like receptor 3; chronic obstructive pulmonary disease; cigarette smoke; lung epithelium; viral mimetic polyinosinic polycytidylic acid

Mesh:

Substances:

Year:  2017        PMID: 29351447      PMCID: PMC5900359          DOI: 10.1152/ajplung.00406.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  46 in total

Review 1.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 2.  Exacerbations of chronic obstructive pulmonary disease.

Authors:  B R Celli; P J Barnes
Journal:  Eur Respir J       Date:  2007-06       Impact factor: 16.671

3.  A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery.

Authors:  David N Nguyen; Phillip Kim; Luis Martínez-Sobrido; Brett Beitzel; Adolfo García-Sastre; Robert Langer; Daniel G Anderson
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

Review 4.  Transcriptional signaling by double-stranded RNA: role of TLR3.

Authors:  Ganes C Sen; Saumendra N Sarkar
Journal:  Cytokine Growth Factor Rev       Date:  2005-02       Impact factor: 7.638

5.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

6.  Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection.

Authors:  Brian D Rudd; Jetse J Smit; Richard A Flavell; Lena Alexopoulou; Matthew A Schaller; Achim Gruber; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

7.  Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains.

Authors:  Masako Tanabe; Mitsue Kurita-Taniguchi; Kaoru Takeuchi; Makoto Takeda; Minoru Ayata; Hisashi Ogura; Misako Matsumoto; Tsukasa Seya
Journal:  Biochem Biophys Res Commun       Date:  2003-11-07       Impact factor: 3.575

8.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

9.  Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes.

Authors:  David Proud; Magdalena H Hudy; Shahina Wiehler; Raza S Zaheer; Minaa A Amin; Jonathan B Pelikan; Claire E Tacon; Tabitha O Tonsaker; Brandie L Walker; Cora Kooi; Suzanne L Traves; Richard Leigh
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

10.  Smoking is associated with shortened airway cilia.

Authors:  Philip L Leopold; Michael J O'Mahony; X Julie Lian; Ann E Tilley; Ben-Gary Harvey; Ronald G Crystal
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

View more
  10 in total

1.  Single-walled carbon nanotubes repress viral-induced defense pathways through oxidative stress.

Authors:  Hao Chen; Sara T Humes; Sarah E Robinson; Julia C Loeb; Indu V Sabaraya; Navid B Saleh; Ram B Khattri; Matthew E Merritt; Christopher J Martyniuk; John A Lednicky; Tara Sabo-Attwood
Journal:  Nanotoxicology       Date:  2019-09-27       Impact factor: 5.913

2.  Cigarette Smoke Extract Disturbs Mitochondria-Regulated Airway Epithelial Cell Responses to Pneumococci.

Authors:  Mahyar Aghapour; Christy B M Tulen; Mohsen Abdi Sarabi; Sönke Weinert; Mathias Müsken; Borna Relja; Frederik-Jan van Schooten; Andreas Jeron; Rüdiger Braun-Dullaeus; Alexander H Remels; Dunja Bruder
Journal:  Cells       Date:  2022-05-28       Impact factor: 7.666

3.  Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Authors:  Douglas G Walker; Tiffany M Tang; Lih-Fen Lue
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

Review 4.  Factors influencing the immunogenicity of influenza vaccines.

Authors:  Simin Wen; Zhengyu Wu; Shuyi Zhong; Mao Li; Yuelong Shu
Journal:  Hum Vaccin Immunother       Date:  2021-03-11       Impact factor: 3.452

5.  Cigarette smoke increases susceptibility to infection in lung epithelial cells by upregulating caveolin-dependent endocytosis.

Authors:  Parker F Duffney; A Karim Embong; Connor C McGuire; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 6.  Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.

Authors:  Hawraa Issa; Ali H Eid; Bassam Berry; Vahideh Takhviji; Abbas Khosravi; Sarah Mantash; Rawan Nehme; Rawan Hallal; Hussein Karaki; Kawthar Dhayni; Wissam H Faour; Firas Kobeissy; Ali Nehme; Kazem Zibara
Journal:  Front Med (Lausanne)       Date:  2021-03-18

7.  Results of the Adult COVID-19 Lifestyle Matching Study.

Authors:  Rui Zhong; Qiong Zhang; Yanfang Qiu; Lingxia Chen; Jianghua Xie; Yongjun Chen; Yajiao Zou; Lei Zhu; Li Tong; Yanhui Zou; Wei Wang; Yuhua Zhou
Journal:  Int J Public Health       Date:  2022-02-18       Impact factor: 3.380

8.  Dysregulated mitochondrial metabolism upon cigarette smoke exposure in various human bronchial epithelial cell models.

Authors:  Christy B M Tulen; Ying Wang; Daan Beentjes; Phyllis J J Jessen; Dennis K Ninaber; Niki L Reynaert; Frederik-Jan van Schooten; Antoon Opperhuizen; Pieter S Hiemstra; Alexander H V Remels
Journal:  Dis Model Mech       Date:  2022-03-28       Impact factor: 5.758

Review 9.  In Vivo and In Vitro Studies of Cigarette Smoke Effects on Innate Responses to Influenza Virus: A Matter of Models?

Authors:  Wenxin Wu; Jeremy S Alexander; Jordan P Metcalf
Journal:  Viruses       Date:  2022-08-20       Impact factor: 5.818

Review 10.  Effects of Cigarette Smoking on Influenza Virus/Host Interplay.

Authors:  Jerald Chavez; Rong Hai
Journal:  Pathogens       Date:  2021-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.